In summary, these findings indicate that a higher frequency of CD103+CD8+ T cells in PB and lower expression levels of PD-1+CD103+CD8+ T cells and TIGIT+CD103+CD8+ T cells are associated with a higher likelihood of achieving CR outcomes in AML and B-ALL. This evidence concerns the gene TIGIT and acute lymphoblastic leukemia.